Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lymphoma 13Neuroblastoma 10Leukemia 9Central Nervous System Neoplasms 9Sarcoma 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Brain Neoplasms 8Hodgkin Disease 5Burkitt Lymphoma 5Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma, Large B-Cell, Diffuse 4Dendritic Cell Sarcoma, Interdigitating 4Medulloblastoma 3Leukemia, Biphenotypic, Acute 3Astrocytoma 3Wilms Tumor 2Testicular Neoplasms 2Teratoma 2Rhabdomyosarcoma 2Rhabdoid Tumor 2Recurrence 2Osteosarcoma 2Myelodysplastic Syndromes 2Multiple Myeloma 2Malignant mesenchymal tumor 2Leukemia, Myeloid, Acute 2Leukemia, Monocytic, Acute 2Kidney Neoplasms 2Cardiotoxicity 2Carcinoma, Renal Cell 2

Interventions

Paclitaxel 9Fluorouracil 9Cisplatin 9Radiotherapy 8Oxaliplatin 6Irinotecan 5Leucovorin 4Docetaxel 4Cetuximab 4Carboplatin 3Taxes 2Surgical Procedures, Operative 2Polymerase Chain Reaction 2Filgrastim 2Capecitabine 2uridine triacetate 1pegylated granulocyte colony-stimulating factor, human 1pegfilgrastim 1durvalumab 1carfilzomib 1atezolizumab 1Vorinostat 1Sorafenib 1Radiosurgery 1Psychiatric Rehabilitation 1Preoperative Exercise 1Platinum 1Lithium 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Esophageal Neoplasms × Granulocyte Colony-Stimulating Factor × Clear all
NCT00069953 2017-02-17

Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction

Radiation Therapy Oncology Group

Phase 2 Completed
43 enrolled 5 charts
Gastrointestinal

Adenocarcinoma Of Esophagus, Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡